Cleared Traditional

K932206 - SYNELISA ANA PROFILE

K932206 is an FDA 510(k) clearance for SYNELISA ANA PROFILE, manufactured by Elias U.S.A., Inc.. The device is a Class 2 Immunology device with product code LJM cleared through the Traditional 510(k) pathway after a 211-day FDA review.

K932206 · Elias U.S.A., Inc. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1993
Decision
211d
Days
Class 2
Risk

K932206 is an FDA 510(k) clearance for the SYNELISA ANA PROFILE. Classified as Antinuclear Antibody (enzyme-labeled), Antigen, Controls (product code LJM), Class II - Special Controls.

Submitted by Elias U.S.A., Inc. (Osceola, US). The FDA issued a Cleared decision on December 3, 1993 after a review of 211 days - an extended review cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5100 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Elias U.S.A., Inc. devices

FDA 510(k) Submission Details - K932206

510(k) Number K932206 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 06, 1993
Decision Date December 03, 1993
Days to Decision 211 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
106d slower than avg
Panel avg: 105d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LJM Device Classification - Class 2, Special Controls

Product Code LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - LJM Antinuclear Antibody (enzyme-labeled), Antigen, Controls

All 79
Devices cleared under the same product code (LJM) and FDA review panel - the closest regulatory comparables to K932206.
SYNELISA ANA TOTAL
K935468 · Elias U.S.A., Inc. · Mar 1994
ELIAS ANA TOTAL
K940641 · Elias U.S.A., Inc. · Mar 1994
AUTOANTIBODY PROFILE-6 ELISA TEST SYSTEM
K933267 · Zeus Scientific, Inc. · Dec 1993
SYNELISA RO ABS / LA ABS
K930209 · Elias U.S.A., Inc. · Jun 1993
KALESTAD ANA MICROPLATE EIA
K924087 · Bio-Rad Laboratories, Inc. · Nov 1992
ACCUTEX SLE LATEX TEST
K924248 · J.S. Medical Assoc. · Nov 1992